Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 5, 2008
Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrolAlexandre Puissant, Sebastien Grosso, Arnaud Jacquel, et al.
Cancer Research|January 28, 2010
Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activationAlexandre Puissant, Guillaume Robert, Nina Fenouille, et al.
Cell Cycle (Georgetown, Tex.)|June 10, 2011
Azacitidine-resistant SKM1 myeloid cells are defective for AZA-induced mitochondrial apoptosis and autophagyThomas Cluzeau, Guillaume Robert, Alexandre Puissant, et al.
Blood Reviews|February 12, 2022
Endothelial cells: major players in acute myeloid leukaemiaSofiane Fodil, Marine Arnaud, Camille Vaganay, et al.
Autophagy|September 30, 2009
Autophagy is an important event for megakaryocytic differentiation of the chronic myelogenous leukemia K562 cell linePascal Colosetti, Alexandre Puissant, Guillaume Robert, et al.
Oncotarget|July 23, 2014
The small heat shock protein B8 (HSPB8) confers resistance to bortezomib by promoting autophagic removal of misfolded proteins in multiple myeloma cellsMohamed-Amine Hamouda, Nathalie Belhacene, Alexandre Puissant, et al.
Blood|November 28, 2013
MUC1-C oncoprotein promotes FLT3 receptor activation in acute myeloid leukemia cellsSuiyang Liu, Li Yin, Dina Stroopinsky, et al.
Cell Cycle (Georgetown, Tex.)|September 27, 2013
Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic propertiesThomas Bertero, Isabelle Bourget-Ponzio, Alexandre Puissant, et al.
Magnetic Resonance in Chemistry : MRC|July 16, 2011
Structure elucidation of the new citharoxazole from the Mediterranean deep-sea sponge Latrunculia (Biannulata) citharistaeGrégory Genta-Jouve, Nellie Francezon, Alexandre Puissant, et al.
Pigment Cell & Melanoma Research|October 20, 2010
The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progressionNina Fenouille, Guillaume Robert, Mélanie Tichet, et al.
Pageof 7